Fasenra receives FDA approval for asthma treatment in children aged 6 to 11 years
Key takeaways: The approval follows positive results from the TATE trial. A new 10 mg dose will be available to accommodate children who weigh less than 35 kg. The FDA approved the use of Fasenra f…
